Table 2 Relationship between PSA value changes and prostate cancer risk
Group | Total follow-up duration (person-years) | No. of prostate cancer cases | Incidence rate of prostate cancer (case/1,000 person-years) | Unadjusted HR (95% CI) | Adjusted HR (95% CI) | ||
|---|---|---|---|---|---|---|---|
Up (n = 967) | 2,369 | 79 | 33.3 | 1.79 (1.20–2.69) | ** | 1.82 (1.21–2.72) | ** |
Down (n = 740) | 1,704 | 33 | 19.4 | 1 | 1 |